Clinical Trial Update: ......SMARTEST Trial...... [Phase 2]

View source ↗

Summary

The SMARTEST trial, a Phase 2 study sponsored by University Health Network in Toronto, has completed. It investigated a treatment for malignant mesothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Mesothelioma, Malignant | Phase 2 | Status: COMPLETED